#6849 CLINICOPATHOLOGIC CHARACTERISTICS IN RENAL THROMBOTIC MICROANGIOPATHY

نویسندگان

چکیده

Abstract Background and Aims Thrombotic microangiopathy (TMA) is a life-threatening condition that can be caused on the background of various mechanisms, converging to severe endotheliopathy often affects kidneys. Morphologic features TMA kidney biopsy have not been systematically studied. We studied diagnostic prognostic role in patients with TMA, either linked coexisting (i.e., secondary TMA) or complement-mediated [C-]TMA). Method Patients an enzymatic activity ADAMTS13 >10% were recruited from Limburg Renal Registry. C-TMA was defined as massive ex vivo C5b9 formation endothelium and/or rare variants complement genes [1]; presence normal regulation. Kidney tissue sections for chronicity; also, C3d staining performed. Results diagnosed 35 39 patients, respectively. The diagnosis based 52 (70%) out 74 systemic hemolysis, is, microangiopathic hemolytic anemia (MAHA) thrombocytopenia, lacking. activity, such as, glomerular thrombosis mesangiolysis, associated MAHA (p = 0.116) thrombocytopenia 0.380). however, C-TMA, lower age higher serum creatinine. did differentiate TMA. A Mayo Clinic Chronicity Score (MCCS) ≥4 increased partial- 0.023) complete renal remission rate 0.030), decreased end-stage disease 0.050). Conclusions Only small proportion initially present suggesting essential histologic examination prevent underdiagnosing. Glomerular mesangiolysis however there no differentiating An MCCS indicates worse outcome

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Clinicopathologic characteristics and outcomes of renal thrombotic microangiopathy in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.

BACKGROUND AND OBJECTIVES Thrombotic microangiopathy (TMA) in ANCA-associated vasculitis (AAV) has been mainly reported in isolated case reports. The aim of this study was to analyze clinical and pathologic characteristics and prognosis of patients with renal TMA in ANCA-associated GN in a large cohort of Chinese patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS Clinical and renal histo...

متن کامل

Thrombotic Microangiopathy in Renal Allografts

The term “thrombotic microangiopathy” (TMA) encompasses non-inflammatory small vessel vasculopathies that are caused by severe endothelial and medial smooth muscle cell injury/necrosis. TMAs can be promoted by a variety of “toxic” stimuli ranging from malignant range hypertension, E. coli infections with bloody diarrhea, radiation, systemic diseases such as scleroderma to iatrogenic events such...

متن کامل

A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy.

Thrombotic microangiopathy (TMA) occurs in IgA nephropathy, but its clinical significance is not well described. We retrospectively examined a series of 128 patients diagnosed with IgA nephropathy between 2002 and 2008 who had a mean follow-up of 44±27 months. In our series, 53% presented with lesions of TMA, acute or organized, in arteries and/or arterioles. Among patients with TMA, 4% were no...

متن کامل

Cyclosporine-associated thrombotic microangiopathy in renal allografts.

BACKGROUND The association between cyclosporine (CsA) and thrombotic microangiopathy (TMA) in renal allografts is well documented. However, predisposing factors and therapy guidelines are not adequately characterized. METHODS We reviewed 188 patients with kidney or kidney-pancreas transplants who were treated between January 1994 and December 1996 with prednisone, CsA, or tacrolimus, and azat...

متن کامل

Progressive bevacizumab-associated renal thrombotic microangiopathy*

Vascular endothelial growth factor (VEGF) is integral to the integrity of the glomerular filtration barrier. Bevacizumab is a humanized monoclonal antibody directed against VEGF with expanding clinical applications for metastatic solid tumours. We describe a case of a 61-year-old female with ovarian cancer and baseline chronic kidney disease who received three doses of bevacizumab and subsequen...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Nephrology Dialysis Transplantation

سال: 2023

ISSN: ['1460-2385', '0931-0509']

DOI: https://doi.org/10.1093/ndt/gfad063c_6849